Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-03-039603
Filing Date
2003-08-19
Accepted
2003-08-19 16:57:26
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDMENT #4 d10ka.htm 10-K/A 47046
3 FUNDED RESEARCH AGREEMENT dex1033.htm EX-10.33 36336
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6995
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6848
6 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex32.htm EX-32 5773
  Complete submission text file 0001193125-03-039603.txt   104957
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21990 | Film No.: 03856244
SIC: 2836 Biological Products, (No Diagnostic Substances)